Non-invasive diagnostics is a process of identifying the disease conditions with minimal incision to the body during diagnosis. Non-invasive diagnostic market is segment of diagnostic market, which was valued at approximately $46 billion in 2011. The non-invasive diagnostic market is mainly driven by increasing rate of prevalence of chronic disease such as CVD, Neurological disease. More than 64.4 million people are suffering from various type of CVD in the U.S, out of which nearly 2,600 people die in a day. The growth of non-invasive diagnostics market has been hindered by availability of non-invasive diagnostic services. Developing countries are not getting non-invasive diagnostic services due to lack of awareness.
Companies involved in manufacturing of non-invasive diagnostic tools are facing challenges because of increasing complexity of diseases. Diagnostic devices used in identification of neurological diseases require some amount of incision that make diagnostic process complex. In order to overcome these problem companies are conducting research on improving diagnostic process in neurological diseases. This report provides strategic intelligence of key developmental strategies adopted by key market players engaged in this business. The report gives patent analysis of the granted patent according to geographies.
The key companies included in the report are: Arthrocare Corp , Charles Russell Bard Inc , Boston Scientific Corporation , Depuy Spine Inc , Hansen Medical , Intuitive Surgical Inc , Karl Storz Endoscope Berlin Gmbh , Pentax Medical Company , Stryker Corporation , Teleflex Medical
GLOBAL MARKET, BY TECHNOLOGIES
GLOBAL MARKET, BY APPLICATIONS
GLOBAL MARKET, BY GEOGRAPHIES